Investor
The latest round brings the company's funding total to $160 million.
The company will be adding a premium version of its fasting app, called Zero Plus.
While the company saw a 25% increase in revenue year-over-year it failed to meet earnings per share expectations.
This comes less than two years after the company closed a $365 million Series B round.
As part of the acquisition Kaiku Health's symptom-tracking tool will be integrated into Elekta's oncology informatics platform.
The young service says that it has been seeing a marked increase in users over the past few months.
Alongside the purchase and service launch, the digital health company also shared news of a $57 million investment from Perceptive Advisors.
The Philadelphia-based startup was designed to help patients with organizing their prescription medications and via online support.
The company also published new research on its biofeedback tool.
The companies will join forces and create a new app called My Next Health, which helps gauge risk for certain conditions, including the coronavirus.